Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
Journal of the European Academy of Dermatology and Venereology, 07/05/2012
Gulliver WP et al. – Ustekinumab may provide a safe and effective new treatment strategy for Hidradenitis suppurativa (HS) in some patients. Interleukin 12/23 inhibition is a potential therapeutic option for patients in which other therapies prove ineffective.